Concerns regarding the financial aspects of kidney transplantation: perspectives of pre-transplant patients and their family members

Clinical Transplantation

Volumn 28, Issue 10, 2014, Pages 1121-1130

  Ganji, Sumitha ^a   Ephraim, Patti L ^b   Ameling, Jessica M ^b   Purnell, Tanjala S ^b   Lewis Boyer, LaPricia L ^c   Boulware, L Ebony ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

end stage renal disease; kidney transplantation; patient perspective; qualitative research; shared decision making

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONFUSION (UNCERTAINTY); DRUG COST; FAMILY ATTITUDE; FEMALE; FINANCIAL DEFICIT; GRAFT RECIPIENT; HEALTH CARE COST; HEALTH INSURANCE; HEALTH INSURANCE ELIGIBILITY; HUMAN; INFORMATION SEEKING; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MEDICAL INFORMATION; PATIENT ATTITUDE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STRUCTURED INTERVIEW;

EID: 85027937149     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12428     Document Type: Article

References (30)

1. Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol 2002: 13: 1358.
2. Laurentine KA, Bramstedt KA. Too poor for transplant: finance and insurance issues in transplant ethics. Prog Transplant 2010: 20: 178.
3. Coorey GM, Paykin C, Singleton-Driscoll LC, Gaston RS. Barriers to preemptive kidney transplantation. Am J Nurs 2009: 109: 28.
4. Schold JD, Gregg JA, Harman JS, Hall AG, Patton PR, Meier-Kriesche HU. Barriers to evaluation and wait listing for kidney transplantation. Clin J Am Soc Nephrol 2011: 6: 1760.
5. Schold JD, Sehgal AR, Srinivas TR, Poggio ED, Navaneethan SD, Kaplan B. Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant 2010: 10: 2008.
6. Keith D, Ashby VB, Port FK, Leichtman AB. Insurance type and minority status associated with large disparities in prelisting dialysis among candidates for kidney transplantation. Clin J Am Soc Nephrol 2008: 3: 463.
7. Goldfarb-Rumyantzev AS, Koford JK, Baird BC et al. Role of socioeconomic status in kidney transplant outcome. Clin J Am Soc Nephrol 2006: 1: 313.
8. United States Renal Data System. http://www.usrds.org/atlas10.aspx. Accessed August 9, 2014.
9. Shoskes DA, Avelino L, Barba L, Sender M. Patient death or renal graft loss within 3 yr of transplantation in a county hospital: importance of poor initial graft function. Clin Transplant 1997: 11: 618.
10. Woodward RS, Schnitzler MA, Lowell JA, Spitznagel EL, Brennan DC. Effect of extended coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants. Am J Transplant 2001: 1: 69.
11. Chapman JR. Compliance: the patient, the doctor, and the medication? Transplantation 2004: 77: 782.
12. National Living Donor Assistance Center. Living Donor Assistance Program. http://www.livingdonorassistance.org. Accessed August 9, 2014.
13. Chisholm MA, Tackett KL, Kendrick BD, DiPiro JT. Assistance programs available for medications commonly used in transplant patients. Clin Transplant 2000: 14: 269.
14. Ephraim PL, Powe NR, Rabb H et al. The providing resources to enhance African American patients' readiness to make decisions about kidney disease (PREPARED) study: protocol of a randomized controlled trial. BMC Nephrol 2012: 13: 135.
15. Ameling JM, Auguste P, Ephraim PL et al. Development of a decision aid to inform patients' and families' renal replacement therapy selection decisions. BMC Med Inform Decis Mak 2012: 12: 140.
16. DePasquale N, Ephraim PL, Ameling J et al. Selecting renal replacement therapies: what do African American and non-African American patients and their families think others should know? A mixed methods study. BMC Nephrol 2013: 14: 9.
17. Thomas DA. A general inductive approach for analyzing qualitative evaluation data. Am J Eval 2006: 27: 237.
18. Sutton TD, Murphy SP. Stressors and patterns of coping in renal transplant patients. Nursing Res 1989: 38: 46.
19. Waterman AD, Stanley SL, Covelli T, Hazel E, Hong BA, Brennan DC. Living donation decision making: recipients' concerns and educational needs. Prog Transplant 2006: 16: 17.
20. Boulware LE, Hill-Briggs F, Kraus ES et al. Identifying and addressing barriers to African American and non-African American families' discussions about preemptive living related kidney transplantation. Prog Transplant 2011: 21: 97.
21. OPTN Bylaws. http://optn.transplant.hrsa.gov/ContentDocuments/OPTN_Bylaws.pdf. Accessed August 8, 2014.
22. Transplant Financial Coordinators Association. http://www.tfcassociation.org. Accessed August 9, 2014.
23. National Kidney Foundation Blog. Congress holds hearing on extending Medicare coverage for immunosuppressive drugs, 2013; http://nkfadvocacy.wordpress.com/2013/06/28/congress-holds-hearing-on-extending-medicare-coverage-for-immunosuppressive-drugs/. Accessed August 9, 2014.
24. United States House of Representatives. H.R. 1428: Comprehensive immuosuppressive drug coverage for kidney transplant patients act of 2013. https://http://www.govtrack.us/congress/bills/113/hr1428/text. Accessed August 9, 2014.
25. American Society of Nephrology. Support S. 323/H.R. 1428. http://www.asn-online.org/policy/webdocs/5-Immunosuppressive.pdf. Accessed August 9, 2014.
26. Axelrod DA, Millman D, Abecassis MM. US Health Care Reform and Transplantation. Part I: overview and impact on access and reimbursement in the private sector. Am J Transplant 2010: 10: 2197.
27. Boulware LE, Troll MU, Plantinga LC, Powe NR. The association of state and national legislation with living kidney donation rates in the United States: a national study. Am J Transplant 2008: 8: 1451.
28. Lunsford SL, Shilling LM, Chavin KD et al. Racial differences in the living kidney donation experience and implications for education. Proq Transplant. 2007: 17: 234.
29. Gore JL, Danovitch GM, Litwin MS, Pham PTT, Singer JS. Disparities in the utilization of live donor renal transplantation. Am J Transplant 2009: 9: 1124.
30. Boulware LE, Troll MU, Wang NY, Powe NR. Public attitudes toward incentives for organ donation: a national study of different racial/ethnic and income groups. Am J Transplant 2006: 6: 2774.